Dare Bioscience, Inc. (DARE) Return on equity 2021–2025
Dare Bioscience, Inc. (DARE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-471.4%FY2025 · since FY2021: -99.8% → -471.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -471.4% | — |
| FY2022 | -278.5% | -178.7 pp |
| FY2021 | -99.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More DARE financial trends
DARE RevenueDARE Net incomeDARE Net marginDARE Gross profitDARE Gross marginDARE Operating incomeDARE Operating marginDARE Operating cash flowDARE Free cash flowDARE Capital expendituresDARE Stock buybacksDARE Dividends paidDARE Total assetsDARE Total liabilitiesDARE Shareholders’ equityDARE overview →